✦ LIBER ✦

T2003 On-Treatment Response-Guided Therapy With Telaprevir Q8h or Q12h Combined With Peginterferon Alfa-2a or Peginterferon Alfa-2B and Ribavirin in Treatment-NaïVE Genotype 1 Hepatitis C (Study C208)

✍ Scribed by Marcellin, Patrick; Forns, Xavier; Goeser, Tobias; Ferenci, Peter; Nevens, Frederik; Carosi, Giampiero; Drenth, Joost PH; Serfaty, Lawrence; De Backer, Koen; van Heeswijk, Rolf; Luo, Don; De Meyer, Sandra; Beumont-Mauviel, Maria

Book ID: 123379303
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 129 KB
Volume: 138
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(10)63899-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

56 ON-TREATMENT RESPONSE-GUIDED THERAPY

56 ON-TREATMENT RESPONSE-GUIDED THERAPY WITH TELAPREVIR Q8H OR Q12H COMBINED WITH PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 1 HEPATITIS C (STUDY C208)

✍ X. Forns; P. Marcellin; P. Ferenci; T. Göser; F. Nevens; G. Carosi; J.P. Drenth; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 55 KB

15 TELAPREVIR (TVR) q8h OR q12h COMBINED

15 TELAPREVIR (TVR) q8h OR q12h COMBINED WITH EITHER PEGINTERFERON (PEG-IFN, P) ALFA-2A OR ALFA-2B AND RIBAVIRIN (RBV, R) IN TREATMENT-NAÏVE GENOTYPE 1 HEPATITIS C: FINAL RESULTS OF THE RANDOMIZED, OPEN-LABEL, MULTICENTER PHASE 2 STUDY C208

✍ M. Colombo; M.G. Rumi; G. Carosi; M. Puoti; P. Marcellin; X. Forns; T. Göser; P. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Response-Guided Therapy With Boceprevir

Response-Guided Therapy With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin Reduces Treatment Duration in NaïVE and Peginterferon Alfa-2B/Ribavirin Previous-Treatment-Failure Patients With HCV Genotype 1

✍ Manns, Michael P. ;Poordad, Fred ;Bacon, Bruce R. ;Bruno, Savino ;Esteban, Rafae 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 258 KB

448 RESPONSE-GUIDED THERAPY WITH BOCEPRE

448 RESPONSE-GUIDED THERAPY WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN REDUCES DURATION IN NAIVE AND PEGINTERFERON ALFA-2B/RIBAVIRIN PREVIOUS-TREATMENT-FAILURE PATIENTS WITH HCV GENOTYPE 1

✍ M.P. Manns; F. Poordad; B.R. Bacon; S. Bruno; R. Esteban; M. Silva; M. Buti; M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Randomized, double-blind, placebo-contro

Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infection

✍ Peter Ferenci; Elisabeth Formann; Hermann Laferl; Michael Gschwantler; Franz Hac 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 182 KB

50 ACTIVITY OF TELAPREVIR ALONE OR IN CO

50 ACTIVITY OF TELAPREVIR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 2 AND 3 HEPATITIS-C PATIENTS: INTERIM RESULTS OF STUDY C209

✍ G.R. Foster; C. Hezode; J.-P. Bronowicki; G. Carosi; O. Weiland; L. Verlinden; R 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB